CURE Pharmaceutical’s Steven Ruhl on raw materials and functional excipients

Steven Ruhl, VP of manufacturing for CURE Pharmaceutical, was featured in a roundtable in the April edition of the American Pharmaceutical Review on “Raw Materials and Functional Excipients.”

“Regulatory and quality expectations of excipients will continue to increase,” said Ruhl, “which has put more pressure on excipient and raw material companies to invest in characterizing functionality and building robust processes to consistently address company needs. This has led to a greater focus on understanding critical material attributes and ranges by both suppliers and customers earlier in the development process.”

Read the full article: Raw Materials and Functional Excipients (American Pharmaceutical Review)

OWC adds two healthcare leaders to client portfolio

OWC has been retained by two healthcare clients to its growing roster. CURE Pharmaceutical (OTC: CURR) is an innovative drug delivery company, and Saban Community Clinic is a federally-qualified health center providing low-cost, integrated health care to the Los Angeles community.

“Healthcare is one of the fastest growing markets in the country, and we are fortunate to work with two innovators,” said Tracy Williams, OWC founder and CEO. “CURE Pharmaceutical and Saban Community Clinic are two organizations that are changing patient’s lives and improving the delivery healthcare to those in need.”

Read the full announcement: Olmstead Williams Communications Adds Two Healthcare Leaders to Client Portfolio (iReach)

San Fernando Valley Business Journal speaks to CURE Pharmaceutical’s new hire

CURE Pharmaceutical has named Vered Gigi as vice president of strategy and business development. The appointment is part of a larger push to build out partnerships within the pharmaceutical industry and test new indications for the company’s primary product.

“CURE has been on stealth mode for a while, developing the technology and the intellectual property,” Gigi said. “Now we’re really moving into phase two of growth and expansion to bring our product to market.”

Read the full article here. (San Fernando Valley Business Journal)

February 7th, 2018|Categories: OWC News|Tags: , , , , |

CURE Pharmaceutical Adds New VP of Strategy and Business Development

CURE Pharmaceutical, an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development.  Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue.

“The CURE team and the technology offer a clear path to a better and much needed patient experience with medications,” said Dr. Vered Gigi. “I am thrilled to be a part of this group to improve the efficacy and safety of new and existing drugs.”

Read full articles:

CURE Pharmaceutical Adds New VP of Strategy and Business Development (Healthcare Dive)

CURE Pharmaceutical Adds New VP of Strategy and Business Development (FirstWord Pharma)

January 25th, 2018|Categories: Client News|Tags: , , , , |